Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats

Psychopharmacology

Volumn 204, Issue 4, 2009, Pages 715-724

  Gatch, Michael B ^a   Rutledge, Margaret A ^a   Carbonaro, Theresa ^a   Forster, Michael J ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

(+) methamphetamine; ( ) 2,5 dimethoxy 4 methylamphetamine (DOM); 3,4 methylenedioxymethylamphetamine (MDMA); Cross substitution; Dimethyltryptamine (DMT); Drug discrimination; Hallucinogen; Lysergic acid diethylamide (LSD); Psychostimulant; Rat

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; LYSERGIDE; METHAMPHETAMINE; N,N DIMETHYLTRYPTAMINE; PSYCHOTROPIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRAINING;

2,5-DIMETHOXY-4-METHYLAMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DISCRIMINATION LEARNING; HALLUCINOGENS; LYSERGIC ACID DIETHYLAMIDE; MALE; METHAMPHETAMINE; N,N-DIMETHYLTRYPTAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67349146022     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1501-z     Document Type: Article

References (54)

1. LM Adams MA Geyer 1985 Effects of DOM and DMT in a proposed animal model of hallucinogenic activity Prog Neuropsychopharmacol Biol Psychiatry 9 121 132 (Pubitemid 15089220)
2. JB Appel WB West WG Rolandi T Alici K Pechersky 1999 Increasing the selectivity of drug discrimination procedures Pharmacol Biochem Behav 64 353 358 (Pubitemid 29438621)
3. LE Baker J Broadbent EK Michael PK Matthews CA Metosh RB Saunders WB West JB Appel 1995 Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3, 4-methylenedioxymethamphetamine; MDMA) Behav Pharmacol 6 263 275
4. RL Balster 1991 Drug abuse potential evaluation in animals Brit J Addict 86 1549 1558
5. Barker SA, Monti JA, Christian ST (1981) N,N-dimethyltryptamine: an endogenous hallucinogen. Int Rev Neurobiol: 83-110
6. J Broadbent JB Appel EK Michael JH Ricker 1992 Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA) Behav Pharmacol 3 443 454
7. PM Callahan JB Appel 1988 Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline J Pharmacol Exp Ther 246 866 870 (Pubitemid 18232470)
8. SG Cooper SR Schiff WH Bridger 1981 Tolerance to behavioral effects of N,N-dimethyltryptamine in mice Biol Psychiatry 16 864 867
9. MM Doat RA Rabin JC Winter 2003 Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD Pharmacol Biochem Behav 74 713 721 (Pubitemid 36126550)
10. SE File 1977 Effects of N,N-dimethyltryptamine on behavioural habituation in the rat Pharmacol Biochem Behav 6 163 168 (Pubitemid 8076008)
11. D Fiorella PA Palumbo RA Rabin JC Winter 1995 The time-dependent stimulus effects of R(-)-2, 5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents Psychopharmacology 119 239 245
12. RS Gable 2007 Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction 102 24 34 (Pubitemid 46006468)
13. JC Gillin J Kaplan R Stillman RJ Wyatt 1976 The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine Am J Psychiatry 133 203 208
14. RA Glennon 1986 Discriminative stimulus properties of phenylisopropylamine derivatives Drug Alc Depend 17 119 134 (Pubitemid 16089055)
15. RA Glennon 1999 Arylalkylamine drugs of abuse: an overview of drug discrimination studies Pharmacol Biochem Behav 64 251 256 (Pubitemid 29438608)
16. RA Glennon R Young JA Rosecrans MJ Kallman 1980 Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities Psychopharmacology 68 155 158 (Pubitemid 10101648)
17. RA Glennon R Young JA Rosecrans GM Anderson 1982 Discriminative stimulus properties of MDA analogs Biol Psychiatry 17 807 814 (Pubitemid 12048365)
18. RA Glennon R Young JM Jacyno M Slusher JA Rosecrans 1983 DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines Eur J Pharmacol 86 453 459 (Pubitemid 13171528)
19. KA Grant 1999 Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures Pharmacol Biochem Behav 64 261 267 (Pubitemid 29438610)
20. JH Halpern 2004 Hallucinogens and dissociative agents naturally growing in the United States Pharmacol Ther 102 131 138 (Pubitemid 38681012)
21. A Hamik SJ Peroutka 1989 1-(m-chlorophenyl) piperazine (mCPP) interactions with neurotransmitter receptors in the human brain Biol Psychiatry 25 569 575 (Pubitemid 19071308)
22. S Helsley D Fiorella RA Rabin JC Winter 1998 A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus Prog Neuropsychopharmacol Biol Psychiatry 22 649 663 (Pubitemid 28281228)
23. RE Heuring SJ Peroutka 1987 Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes J Neurosci 7 894 903 (Pubitemid 17032607)
24. TUC Jarbe 1980 LSD-25 as a discriminative stimulus for response selection by pigeons Pharmacol Biochem Behav 13 549 554 (Pubitemid 10024773)
25. P Jenner CD Marsden CM Thanki 1980 Behavioural changes induced by N,N-dimethyl-tryptamine in rodents Br J Pharmacol 69 69 80 (Pubitemid 10101678)
26. N Khorana MR Pullogurla R Young RA Glennon 2004 Comparison of the discriminative stimulus effects of 3, 4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization Drug Alc Depend 74 281 287 (Pubitemid 38759783)
27. B Kovacic EF Domino 1976 Tolerance and limited cross-tolerance to the effects of N,N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat J Pharmacol Exp Ther 197 495 502
28. B Kovacic LJ Wang Lu D Ruffing EF Domino 1978 Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat Eur J Pharmacol 47 37 44 (Pubitemid 8244116)
29. D Kueh LE Baker 2007 Reinforcement schedule effects in rats trained to discriminate 3, 4-methylenedioxymethamphetamine (MDMA) or cocaine Psychopharmacology 189 447 457 (Pubitemid 44791215)
30. RA Lyon M Titeler MR Seggel RA Glennon 1988 Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens Eur J Pharmacol 145 291 297 (Pubitemid 18018849)
31. DJ McKenna 2004 Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges Pharmacol Ther 102 111 129 (Pubitemid 38681011)
32. DJ McKenna SJ Peroutka 1989 Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-) 2, 5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin J Neurosci 9 3482 3490 (Pubitemid 19260020)
33. DJ McKenna GH Towers F Abbott 1984 Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca J Ethnopharmacol 10 195 223 (Pubitemid 14081500)
34. National Research Council (2003) Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. The National Academies Press, The National Academies Press
35. DE Nichols 2004 Hallucinogens Pharmacol Ther 101 131 181 (Pubitemid 38167565)
36. R Oberlender DE Nichols 1988 Drug discrimination studies with MDMA and amphetamine Psychopharmacology 95 71 76 (Pubitemid 18111707)
37. J Ott 1999 Pharmahuasca: human pharmacology of oral DMT plus harmine J Psychoactive Drugs 31 171 177 (Pubitemid 29321429)
38. PA Pierce SJ Peroutka 1989 Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex Psychopharmacology 97 118 122 (Pubitemid 19020394)
39. J Riba M Valle G Urbano M Yritia A Morte MJ Barbanoj 2003 Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics J Pharmacol Exp Ther 306 73 83 (Pubitemid 36734359)
40. DM Ruffing EF Domino 1983 Interaction of synthetic opioid metenkephalin peptide analogs, Lilly 127623 and FK 33-824 with indole hallucinogens: antagonism of N,N-dimethyltryptamine- and LSD-induced disruption of food-rewarded bar pressing behavior in the rat Psychopharmacology 80 315 318
41. B Sadzot JM Baraban RA Glennon RA Lyon S Leonhardt CR Jan M Titeler 1989 Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis Psychopharmacology 98 495 499 (Pubitemid 19193897)
42. RJ Sbordone JA Wingard DA Gorelick ML Elliott 1979 Severe aggression in rats induced by mescaline but not other hallucinogens Psychopharmacology (Berl) 66 275 280 (Pubitemid 10173624)
43. MD Schechter 1998 MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats Pharmacol Biochem Behav 59 265 270 (Pubitemid 28072716)
44. RI Schoenfeld 1976 Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat Science 192 801 803
45. RL Smith H Canton RJ Barrett E Sanders-Bush 1998 Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors Pharmacol Biochem Behav 61 323 330 (Pubitemid 28498215)
46. DM Stoff EA Moja JC Gillin RJ Wyatt 1977 Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttlebox avoidance Biol Psychiatry 12 339 346 (Pubitemid 8122058)
47. Stolerman IP (1993) Drug discrimination. In: Van Haaren F (ed) Methods in Behavioral Pharmacology. Elsevier, Amsterdam, pp 217-243
48. RJ Strassman CR Qualls EH Uhlenhuth R Kellner 1994 Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale Arch Gen Psychiatry 51 98 108 (Pubitemid 24054311)
49. RJ Strassman CR Qualls LM Berg 1996 Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans Biol Psychiatry 39 784 795 (Pubitemid 26156742)
50. S Szara LH Rockland D Rosenthal JH Handlon 1966 Psychological effects and metabolism of N,N-diethyltryptamine in man Arch Gen Psychiatry 15 320 329
51. JK Walters MH Sheard M Davis 1978 Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats Pharmacol Biochem Behav 9 87 90 (Pubitemid 8396472)
52. WB West A Lou K Pechersky ME Chachich JB Appel 2000 Antagonism of a PCP drug discrimination by hallucinogens and related drugs Neuropsychopharmacology 22 618 625 (Pubitemid 30219405)
53. Winter JC (2009) Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines. Psychopharmacology in press
54. JC Winter KC Rice DJ Amorosi RA Rabin 2007 Psilocybin-induced stimulus control in the rat Pharmacol Biochem Behav 87 472 480 (Pubitemid 47238403)